Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Pharma’s pigeons

If it can adapt, a lucrative new niche is opening up for pharma

- PMLiVE

CRF Health boosts leadership team

John Blakely and Risto Enbuska join the electronic patient reported outcomes firm

- PMLiVE

AbbVie wins key approval for hep C pill Viekira Pak

Prices all-oral treatment fractionally lower than rivals from Gilead

Eli Lilly HQ

Lilly signs $570m deal for next-gen Humalog

Licenses improved version of its insulin blockbuster from Adocia

UK Life Sciences Strategy - one year on

NHS set to deliver ‘world-leading’ genomics centres

Genetics research plans could help create more bespoke medicines

- PMLiVE

GSK squares up to Merck with shingles vaccine data

Trial shows vaccine cut the risk of shingles in over 50s by 97%

- PMLiVE

Orexigen’s obesity pill Mysimba set for European approval

But sales of the treatment are only predicted to reach $200m by 2016

- PMLiVE

‘Major step forward’ as EMA recommends first stem cell therapy

But wants more clinical trial data to shore up orphan drug's marketing licence

Lannett appoints Teva’s Michael Bogda as president

He served as VP of technical operations in for Teva’s Americas division

- PMLiVE

Making success measurable

Companies cannot overlook effective evaluation

- PMLiVE

Blue Latitude boosts its team

Appointments follow new business wins for the company

- PMLiVE

NICE backs three ulcerative colitis treatments

Remicade, Simponi and Humira recommended for NHS reimbursement

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links